Jens Lundgren

41PUBLICATIONS
257CO-AUTHORS
Innate immunityImmunogenetics (incl. genetic immunology)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 02, 2026
Factors Associated with Persistently Increased IL-6 Levels in People with HIV.

|Aug 18, 2026
Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

|Jun 25, 2026
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.

|May 30, 2026
Early high-resolution immune profiles are associated with survival, relapse and graft-versus-host-disease after allogeneic hematopoietic cell transplantation.

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

|Aug 18, 2025
Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines.

Omid Rezahosseini, Jens Ulrik Stæhr Jensen, Hana Khajeh Rahimi

Pageof 7

Frequent Collaborators

8 joint publications

Sisse Rye Ostrowski

6 joint publications

Joanne Reekie

6 joint publications

Thomas Benfield

6 joint publications

Carsten Utoft Niemann